Login to Your Account



Celtic Pharma’s New Acquisition Adds Drug Delivery Technology

By Jennifer Boggs


Friday, February 24, 2006
Global private equity firm Celtic Pharmaceutical Holdings LP gained access to a targeted drug delivery technology from IDEA AG, as well as clinical and preclinical products in pain and inflammation, dermatitis and psoriasis. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription